2019
DOI: 10.1016/j.transproceed.2019.01.088
|View full text |Cite
|
Sign up to set email alerts
|

The Analysis of Posthepatectomy Liver Failure Incidence and Risk Factors Among Right Liver Living Donors According to International Study Group of Liver Surgery Definition

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 31 publications
0
3
0
Order By: Relevance
“…Although some studies already exclude grade A in their analyses, others consider all grades together as PHLF. 23,24 Furthermore, the range of postoperative morbidity experienced among those with grade B PHLF suggests that this category may be amenable to further substratification. Ultimately, formalizing the distinction between grades could address inconsistent operationalization of PHLF in future studies and optimize our ability to develop models that accurately predict clinically meaningful liver failure.…”
Section: Discussionmentioning
confidence: 99%
“…Although some studies already exclude grade A in their analyses, others consider all grades together as PHLF. 23,24 Furthermore, the range of postoperative morbidity experienced among those with grade B PHLF suggests that this category may be amenable to further substratification. Ultimately, formalizing the distinction between grades could address inconsistent operationalization of PHLF in future studies and optimize our ability to develop models that accurately predict clinically meaningful liver failure.…”
Section: Discussionmentioning
confidence: 99%
“…Our finding may be clinically relevant: for instance, when the risk of PHLF must be reduced to zero, as in livingdonor hepatectomy [5,36,37], the safest cutoff value of remnant liver function (FLR-F > 2.79%/min/m 2 or HIBAi > 23.8%) should be used. On the contrary, if the risk of dropout between stages, as in PVE or TSH, is deemed to be higher than the risk of grade A PHLF [22], a lower cutoff can be considered (FLR-F ≥ 1.85%/min/m 2 or HIBAi ≥ 16.8%).…”
Section: Discussionmentioning
confidence: 89%
“…The long‐term morbidity associated with organ transplantation in patients with hepatoblastoma, the role of long‐term immunosuppression and potential development of secondary malignancy have not been assessed conclusively. Donor morbidity is important. Despite morbidity remaining low for left lateral segment donation (which forms the majority of grafts in children), there always remains a finite risk of serious complications and mortality.…”
Section: Discussionmentioning
confidence: 99%